Cycle Nation Communities program to help adults start cycling in Glasgow
Official title: Effectiveness and Cost-effectiveness of a Community-based Nine-week Multi-component Group-based Cycling Intervention Versus a Single Cycle Training Session to Increase Cycling Participation: the Cycle Nation Communities Randomised Controlled Trial
Run by University of Glasgow · NCT07005674 · Data updated 2026-11-12
This project will test whether a nine-week Cycle Nation group program helps adults who don’t regularly cycle to ride more and improve health and wellbeing compared with a single standard cycling session.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 268 (estimated) |
| Sponsor | University of Glasgow Academic / other |
| Locations | 1 site (Glasgow) |
| Status | Recruiting |
| Started | May 27, 2025 |
| Main results expected | December 2026 |
| Study ends | February 2027 |
| Registry record updated | October 7, 2025 |
| Trial ID | NCT07005674 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (18+) in the Glasgow area who can already ride a bicycle, currently cycle less than once per month, can speak basic English, can attend at least six of nine in-person sessions, and have no contraindication to moderate physical activity.
✕Probably not a fit
People who already cycle regularly, cannot ride a bicycle, have medical contraindications to moderate exercise, or cannot attend in-person sessions are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized controlled comparison of a nine-week, multi-component, group-based Cycle Nation programme versus a single standard cycling training session delivered by Cycling Scotland. Adults who can ride a bike but currently cycle less than once per month will be randomly allocated to one of the two arms and followed up at baseline, immediately post-programme, and at 12 months. Primary outcomes are self-reported cycling behaviour along with measures of health and wellbeing; the trial also includes a cost-effectiveness analysis and a process evaluation. Sessions are delivered in person in Glasgow and participants are expected to attend at least six of nine sessions for the intervention arm.
Why it matters
Potential benefit: If successful, the programme could help non-cyclists establish regular cycling habits, improving fitness and mental wellbeing while potentially reducing transport-related emissions.
How similar studies have gone: Similar multi-component, group-based cycling programmes have been piloted (including the original Cycle Nation workplace pilot) and shown promising uptake and short-term increases in cycling, but large randomized long-term effectiveness data remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Can ride a bicycle Self-identified infrequent cyclists (currently cycle less than once per month) Aged 18 years or over Willing to provide informed consent Willing to partake in measurements Willing to be randomised to intervention or control arm Have a good understanding of the English language Not have a contraindication to moderate intensity physical activity as assessed by the adapted Physical Activity Readiness Questionnaire-Plus (PAR-Q+) Able to attend in-person sessions (at least 6 out of 9 sessions) Intend to still be in the UK by November 2026 Exclusion Criteria: Cannot cycle (i.e. cannot balance and/or have never learnt to cycle) Frequent or regular cyclists (i.e. currently cycle at least once a month, confident riding on roads) Less than 18 years old Not willing to provide informed consent Not willing to partake in measurements Not willing to be randomised to the intervention or control arm Cannot speak basic English Have a contraindication to moderate intensity physical activity as assessed by the adapted Physical Activity Readiness Questionnaire-Plus (PAR-Q+) Not able to attend in-person sessions (less than 6 out of 9 sessions) Not intending to still be in the UK by November 2026
Where it's running
-
University of Glasgow
Glasgow, United Kingdom Recruiting
Study contacts
- Principal investigator: Jason Gill, PhD — University of Glasgow
- Study coordinator: Fernanda Gabler Trisotti, PhD
- Email: gallanttravel@glasgow.ac.uk
- Phone: 07886700868
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nailfold Capillaroscopy in Pulmonary Hypertension
This study tests whether nailfold capillary scans correlate with invasive lung blood pressure measurements and whether these patterns change with PH treatment.
-
Hesperidin for better thinking in overweight older adults
In adults aged 55–75 who are overweight, taking hesperidin or a placebo for 10 weeks will show whether the citrus flavonoid can improve thinking skills like memory, attention, and problem-solving.
-
Community food markets in Glasgow to improve access to affordable, nutritious food
A community-led food market in Glasgow is being tested to see if it helps low-income residents buy more fruits, vegetables, fish, and fiber-rich foods.
-
How common dietary fats change gut bacteria and metabolic markers
We will test whether replacing part of daily fat with butter, coconut oil, olive oil, or sunflower oil for two weeks changes gut bacteria and related blood markers in healthy adults aged 20–50.
-
Biologics plus a 6-week enteral nutrition plan for children with Crohn's disease
This will test whether giving children and teens (6–18) with active Crohn's disease a 6-week specialised liquid diet alongside biologic drugs helps them achieve and stay in remission.
-
How vitamin C affects gut bacteria and their activity in healthy adults
This study will test whether taking a moderate (200 mg) then a high (1000 mg) daily dose of vitamin C changes gut bacteria composition and short-chain fatty acid levels in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.